CULLINAN THERAPEUTICS INC. - COMMON STOCK

Cullinan Oncology Announces Appointment of Jacquelyn Sumer as Chief Legal Officer

15 8月 2022 13:57:42 条件 Nasdaq GlobeNewswire

Cullinan Oncology Provides Corporate Update and Reports Second Quarter 2022 Financial Results

10 8月 2022 04:00:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 8月 2022 13:55:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Participate in William Blair Biotech Focus Conference

05 7月 2022 13:01:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 7月 2022 13:38:19 条件 Nasdaq GlobeNewswire

Cullinan Oncology and Taiho Pharmaceutical Complete Agreement for Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417

23 6月 2022 05:00:01 条件 Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 6月 2022 14:00:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Present Updated Data Demonstrating the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting

31 5月 2022 05:00:01 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Host Analyst and Investor Briefing at 2022 ASCO Annual Meeting

26 5月 2022 05:45:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Present at H.C. Wainwright Global Investment Conference

19 5月 2022 05:00:01 条件 Nasdaq GlobeNewswire

Cullinan Oncology Provides Corporate Update and Reports First Quarter 2022 Financial Results

16 5月 2022 03:45:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize CLN-081/TAS6417 and Taiho’s Acquisition of Cullinan Pearl

11 5月 2022 23:00:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 5月 2022 14:10:24 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Present Updated Data Highlighting the Therapeutic Potential of CLN-081 in Patients with EGFR Exon 20 Insertion Mutation Positive Non-Small Cell Lung Cancer at the 2022 ASCO Annual Meeting

27 4月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Participate in Upcoming Virtual Healthcare Conferences

05 4月 2022 05:00:01 条件 Nasdaq GlobeNewswire

Cullinan Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 4月 2022 13:34:22 条件 Nasdaq GlobeNewswire

Cullinan Oncology Announces Clinical and Regulatory Update for CLN-081 in NSCLC EGFR Exon 20 Patients

28 3月 2022 13:01:00 条件 Nasdaq GlobeNewswire

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

17 3月 2022 04:08:06 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Host CLN-081 Regulatory Update Webinar on March 28, 2022

17 3月 2022 04:00:01 条件 Nasdaq GlobeNewswire

Cullinan Oncology to Present at the Barclays Global Healthcare Conference

09 3月 2022 05:00:02 条件 Nasdaq GlobeNewswire